Poland· PL-100475024
Vyvgart
A efgartigimod alfa product containing efgartigimod alfa, registered in Poland by argenx BV. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Efgartigimod alfa is registered in 4 of 19 countries.
Countries holding a registration under ATC L04AA58 (efgartigimod alfa), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Efgartigimod alfa · ATC L04AA58
4 / 19 countries
- Belgiumprice
- Canada
- Ireland
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Efgartigimod alfa
- Manufacturer
- argenx BV
- Country
- Poland (PL)
- ATC code
- L04AA58
- ATC class
- Efgartigimod alfa
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin04150197302503
- gtin04150179912881
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Efgartigimod alfa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumVyvgart 20 mg/mlArgenx
- SwitzerlandVyvgart 400 mg/20ml, solution à diluer pour perfusionargenx Switzerland SA
- CzechiaVYVGARTargenx BV, Gent
- FinlandVyvgartArgenx
- IrelandVyvgart 20 mg/mL concentrate for solution for infusionArgenx
- IcelandVyvgartArgenx BV
- SwedenVyvgart 20 mg/ml Koncentrat till infusionsvätska, lösningArgenx
- FranceVYVGART 1 000 mg, solution injectable en seringue préremplieARGENX (BELGIQUE)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vyvgart
- Liechtenstein · Vyvgart
- Norway · Vyvgart
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e8d279e1-f695-47e6-8578-b540e36e7176 GET /v1/drugs/e8d279e1-f695-47e6-8578-b540e36e7176?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "20 mg/ml",
"packaging": "04150197302503 ¦ Rpz ¦ EU/1/22/1674/001 ¦ 147348\n1 fiol. 20 ml\n¦ UR/Z/4b/178/22 - 04150179912881 ¦ UR/Z/4b/055/23 - 04150179912881 ¦ UR/Z/4b/081/24 - 04150179912881 ¦ UR/Z/4b/022/24 - 04150179912881 ¦ UR/Z/4b/029/23 - 04150179912881 ¦ UR/Z/4b/133/23 - 04150179912881 ¦ UR/Z/4b/181/24 - 04150179912881 ¦ UR/Z/4b/066/25 - 04150179912881 ¦ UR/Z/4b/196/25 - 04150179912881 ¦ UR/Z/4b/290/25 - 04150179912881 ¦ UR/Z/4b/045/26 - 04150179912881 ¦ UR/Z/4b/210/26 - 04150179912881 ¦ UR/Z/4b/234/26 - 04150179912881 ¦ UR/Z/4b/257/26 - 04150179912881",
"substance": "Efgartigimod alfa 20 mg/ml",
"common_name": "Efgartigimod alfa",
"pl_product_id": "100475024",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about efgartigimod alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.